Filing Flows › AtriCure (ATRC) › Q3 2025
AtriCure (ATRC) Q3 2025 earnings results (third quarter 2025)
10-Q filed Oct 30, 2025
AtriCure (ATRC) reported revenue of $134M for the third quarter 2025 (Q3 2025), +16% from a year earlier and -1% from the quarter before. Operating margin was 0.2%, net loss $267K (0.2% of revenue).
AtriCure, Q3 2025: revenue $134M (+16% year over year), operating margin 0.2%, net loss $267K, operating cash flow $26.7M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $134M | -1% | +16% |
| Operating profit | $208K | — | — |
| Net earnings | −$267K | — | — |
| Operating cash flow | $26.7M | +24% | +34% |
| Free cash flow | $24.1M | +27% | +47% |
What changed
Revenue was $134.3M in Q3 2025, up 16% year over year and down 1% from the previous quarter.
Gross margin was 75.5%, up 0.6 points from a year earlier. Operating profit was $208K, a 0.2% margin (up 6.5 points year over year). Operating expenses grew 7% against revenue growth of 16%. The quarter ended with a net loss of $267K, narrower than the previous quarter's $6.2M loss. Net interest and other expense of $294K was the main reason.
Operating cash flow was $26.7M (up 34% year over year). Non-cash charges added back $5.2M of depreciation and amortization and $12.4M of share-based compensation. Working capital and other items added $9.4M. Capital expenditures of $2.6M left free cash flow of $24.1M.
Questions
What was AtriCure's revenue in the third quarter 2025?
AtriCure (ATRC) reported revenue of $134M for the third quarter 2025 (Q3 2025), +16% from a year earlier and -1% from the quarter before.
Was AtriCure profitable in the third quarter 2025?
Operating profit was $208K (0.2% of revenue) and net loss $267K.
Source: AtriCure 10-Q on SEC EDGAR.